Search Results - "Barber, Lisa G"

Extracellular vesicular microRNAs as potential biomarker for early detection of doxorubicin‐induced cardiotoxicity by Beaumier, Amelie, Robinson, Sally R., Robinson, Nicholas, Lopez, Katherine E., Meola, Dawn M., Barber, Lisa G., Bulmer, Barret J., Calvalido, Jerome, Rush, John E., Yeri, Ashish, Das, Saumya, Yang, Vicky K.

“…Background Long‐term use of doxorubicin (DOX) is limited by cumulative dose‐dependent cardiotoxicity. Objectives Identify plasma extracellular vesicle…”
Get full text

Safety and toxicity of combined oclacitinib and carboplatin or doxorubicin in dogs with solid tumors: a pilot study by Barrett, Laura E, Gardner, Heather L, Barber, Lisa G, Sadowski, Abbey, London, Cheryl A

“…Oclacitinib is an orally bioavailable Janus Kinase (JAK) inhibitor approved for the treatment of canine atopic dermatitis. Aberrant JAK/ Signal Transducer and…”
Get full text

Thyroid tumors in dogs and cats by Barber, Lisa G

“…The clinical presentation and biologic behavior of thyroid tumors vary widely among dogs, cats, and human beings. Although thyroid tumors in dogs are rare,…”
Get more information

Effects of a high‐protein, increased‐fibre, dry diet supplemented with omega‐3 fatty acids on quality of life in dogs undergoing chemotherapy by Heinze, Cailin R., Burgess, Kristine E., Barber, Lisa G., Rassnick, Kenneth M., Post, Gerald S., Segaloff, Richard, Bayle, Julie

“…Quality of life (QOL) in dogs with cancer is a key consideration in the assessment of cancer treatment options. Despite interest in dietary strategies to…”
Get full text

Household chemical exposures and the risk of canine malignant lymphoma, a model for human non-Hodgkin’s lymphoma by Takashima-Uebelhoer, Biki B., Barber, Lisa G., Zagarins, Sofija E., Procter-Gray, Elizabeth, Gollenberg, Audra L., Moore, Antony S., Bertone-Johnson, Elizabeth R.

“…Epidemiologic studies of companion animals offer an important opportunity to identify risk factors for cancers in animals and humans. Canine malignant lymphoma…”
Get full text

Clinical characteristics of doxorubicin‐associated alopecia in 28 dogs by Falk, Elizabeth F., Lam, Andrea T. H., Barber, Lisa G., Ferrer, Lluis

“…Background Chemotherapy‐induced alopecia (CIA) is common in humans, but there are limited reports describing the clinical features of CIA in dogs. Objectives…”
Get full text

Ulnar osteosarcoma in dogs: 30 cases (1992-2008) by Sivacolundhu, Ramesh K, Runge, Jeffrey J, Donovan, Taryn A, Barber, Lisa G, Saba, Corey F, Clifford, Craig A, de Lorimier, Louis-Philippe, Atwater, Stephen W, DiBernardi, Lisa, Freeman, Kim P, Bergman, Philip J

“…To examine the biological behavior of ulnar osteosarcoma and evaluate predictors of survival time in dogs. Retrospective case series. 30 dogs with primary…”
Get full text

Comparative aspects and clinical outcomes of canine renal hemangiosarcoma by Locke, J.E, Barber, L.G

“…Background: Hemangiosarcoma (HSA) is a common solid tumor of the spleen, heart, and skin of dogs. Renal HSA represents an uncommon anatomic variant, with…”
Get full text

Environmental tobacco smoke and canine urinary cotinine level by Bertone-Johnson, Elizabeth R., Procter-Gray, Elizabeth, Gollenberg, Audra L., Ryan, Michele B., Barber, Lisa G.

“…Epidemiologic studies of companion animals such as dogs have been established as models for the relationship between exposure to environmental tobacco smoke…”
Get full text

Prognostic factors for survival of dogs with inguinal and perineal mast cell tumors treated surgically with or without adjunctive treatment: 68 cases (1994-2002) by Cahalane, Alane Kosanovich, Payne, Sarah, Barber, Lisa G, Duda, Lillian E, Henry, Carolyn J, Mauldin, Glenna E, Frimberger, Angela E, Cotter, Susan M, Moore, Antony S

“…To determine the prognostic factors for survival and tumor recurrence in dogs with cutaneous mast cell tumors (MCTs) in the perineal and inguinal regions…”
Get full text

Pilot study evaluating the tolerability of a 3 Gy × 10 daily fraction 3D‐conformal palliative radiation therapy protocol plus toceranib for the treatment of measurable carcinomas in the dog by Keyerleber, Michele A., Barber, Lisa G.

“…The use of radiation therapy in conjunction with small molecule inhibitors is an appealing treatment combination for non‐resectable carcinomas, which tend to…”
Get full text

Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs by LeBlanc, Amy K, Mazcko, Christina N, Cherukuri, Aswini, Berger, Erika P, Kisseberth, William C, Brown, Megan E, Lana, Susan E, Weishaar, Kristen, Flesner, Brian K, Bryan, Jeffrey N, Vail, David M, Burton, Jenna H, Willcox, Jennifer L, Mutsaers, Anthony J, Woods, J Paul, Northrup, Nicole C, Saba, Corey, Curran, Kaitlin M, Leeper, Haley, Wilson-Robles, Heather, Wustefeld-Janssens, Brandan G, Lindley, Stephanie, Smith, Annette N, Dervisis, Nikolaos, Klahn, Shawna, Higginbotham, Mary Lynn, Wouda, Raelene M, Krick, Erika, Mahoney, Jennifer A, London, Cheryl A, Barber, Lisa G, Balkman, Cheryl E, McCleary-Wheeler, Angela L, Suter, Steven E, Martin, Olya, Borgatti, Antonella, Burgess, Kristine, Childress, Michael O, Fidel, Janean L, Allstadt, Sara D, Gustafson, Daniel L, Selmic, Laura E, Khanna, Chand, Fan, Timothy M

“…The mTOR pathway has been identified as a key nutrient signaling hub that participates in metastatic progression of high-grade osteosarcoma. Inhibition of mTOR…”
Get full text

Ocular Lymphangiosarcoma in a Horse by Gornik, Kara R., Pirie, Christopher G., Barber, Lisa G., Beamer, Gillian L.

“…An 18-year-old Percheron cross mare presented to the Cummings School of Veterinary Medicine at Tufts University for evaluation of progressive corneal clouding…”
Get full text

Combined doxorubicin and cyclophosphamide chemotherapy for nonresectable feline fibrosarcoma by Barber, L G, Sørenmo, K U, Cronin, K L, Shofer, F S

“…A retrospective evaluation was performed on 12 cats with nonresectable, histopathologically confirmed fibrosarcomas that were treated with doxorubicin and…”
Get more information